Clinical characteristics and treatment outcome of children with intraocular retinoblastoma: A report from a Chinese cooperative group

Pediatric Blood and Cancer

Volumn 57, Issue 7, 2011, Pages 1113-1116

  Gao, Yi Jin ^a   Qian, Jiang ^b   Yue, Han ^b   Yuan, Yi Fei ^b   Xue, Kang ^b   Yao, Yi Qun ^b  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Cancer; Chemoreduction; Chemotherapy; Retinoblastoma

Indexed keywords

CARBOPLATIN; COTRIMOXAZOLE; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; CHINESE; CONJUNCTIVITIS; CONTROLLED STUDY; CRYOTHERAPY; DISEASE CLASSIFICATION; ENUCLEATION; FEMALE; HUMAN; INFANT; INTRAOCULAR RETINOBLASTOMA; LEUKOKORIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SCHOOL CHILD; STRABISMUS; SURVIVAL RATE; TRANSPUPILLARY THERMOTHERAPY; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053922790     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23002     Document Type: Article

References (17)

1. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin in Ophthalmol 2006; 17: 228-234.
2. Li B, Sun X-L. Recognize the value of the individually combined therapy for children with retinoblastoma [In Chinese]. Zhonghua Yan Ke Za Zhi 2007; 43: 481-483.
3. Shields Cl, Mashayekhi A, Demirci H, et al. A practical approach to management of retinoblastoma. Arch Ophthalmol 2004; 122: 729-735.
4. Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005; 200: 41-53.
5. Shields CL, De Potter P, Himelstein BP, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1330-1338.
6. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular. J Clin Oncol 2000; 18: 12-17.
7. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 2009; 93: 21-23.
8. Bonanomi MTBC, Almeida MTAd, Cristofani LM, et al. Retinoblastoma: a three-year-study at a Brazilian medical school hospital. Clinics (Sao Paulo) 2009; 64: 427-434.
9. Leal-Leal C, Flores-Rojo M, Median-Sanxon A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004; 88: 1074-1077.
10. Dondey JC, Staffieri S, Mckenzie J, et al. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes. Clin Experiment Ophthalmol 2004; 32: 354-359.
11. Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control 2004; 11: 317-327.
12. MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol 2009; 93: 33-37.
13. Pearce MS, Parker L. Childhood cancer registration in the developing world: Still more boys than girls. Int J Cancer 2001; 91: 402-406.
14. Abramson DH, Frank CM, Susman M, et al. Presenting signs of retinoblastoma. J Pediatr 1998; 132: 505-508.
15. Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc 2004; 102: 35-44; discussion-5.
16. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005; 46: 2683-2691.
17. Zhao J-Y. From R-E staging system to IRC system: the change of primary therapy for retinoblastoma [In Chinese]. Yan Ke 2007; 16: 368-372.